PharmaForceIQ's AI omnichannel platform traced 97% of first-year new prescriptions to its triggers and engagements.
A small sales team and tight budget faced a crowded lung cancer market. PharmaForceIQ identified patient triggers and HCP targets from real-world data and ran message sequences across Veeva, digital and Medscape Next Best Engagement. The page reports engagement doubled versus benchmarks, 97% of new prescriptions traced to platform triggers and Medscape accounting for about 45% of engagements.
PharmaForceIQ is an AI-driven HCP engagement and omnichannel orchestration company that acquired Aktana, used by pharma brands for trigger-based launch and non-personal promotion
This sits in the Scale & Govern stage of the AI use-case lifecycle: Named examples from the tools pharma teams use to monitor, govern and keep validating an AI system once it is already live in production.
Published by PharmaForceIQ on its own site — read the original case study on pharmaforceiq.com ↗
Related use cases
- 01PharmaForceIQ ran lab- and claims-triggered optichannel journeys that lifted new prescriptions 22% in 12 months.
- 02PharmaForceIQ used predictive targeting and trigger-based journeys to triple the year-one launch forecast.
- 03PharmaForceIQ's trigger-based platform doubled HCP engagement from 14% to 32% in six months.
- 04Day One used PharmaForceIQ optichannel marketing for a rare pediatric oncology launch with 60% of new prescribers attributed to it.
- 05PharmaForceIQ covered vacant territories with digital-only optichannel campaigns, lifting unique prescribers 41%.
- 06PharmaForceIQ used lookalike audience modelling to lift website quality visits 195% within one quarter on a small budget.